Diabetes

Newest Diabetes Information

6 Best Peptides for Type 1 Diabetes

People managing Type 1 Diabetes look at a wider range of peptides than most guides cover, from the one FDA-approved peptide adjunct to off-label GLP-1 medications, experimental immunotherapy candidates, and research compounds used in community protocols. This guide covers six compounds that come up repeatedly in the research and in real-world T1D discussions, ordered by how prominently each appears in clinical evidence and documented use, not ranked as a recommendation of one over another. The evidence is honestly mixed: some have human trial data, some rest on animal models, and some are community-reported with no clinical validation behind them. The right fit depends on where you are in your T1D journey, what you are managing for, and what you build with a personalized plan.

Diabetes 10 min read

6 Best Peptides for Type 2 Diabetes

Six peptide-based compounds stand out for Type 2 Diabetes in 2026, ranging from FDA-approved medications with deep Phase 3 trial programs to investigational dual and triple agonists still working through clinical development. The field is built around GLP-1 receptor agonists, a class of synthetic peptides that lower blood sugar by stimulating insulin release, slowing digestion, and reducing appetite. Tirzepatide and semaglutide anchor the approved end of the list; retatrutide, survodutide, and mazdutide represent the investigational wave generating the most active discussion. The entries are ordered by how prominently each compound appears in research and real-world use, not as a recommendation of one over another, and personalized guidance on which one fits your situation belongs in the MyPeptidePal app.

Diabetes 11 min read

6 Best Peptides for Diabetes

Six peptides dominate the conversation when people search for diabetes management options in 2026, and they span a wide range of evidence: from FDA-approved GLP-1 receptor agonists backed by large-scale randomized controlled trials to investigational compounds still working through Phase 2 data and small-scale human trials. This guide covers each one honestly, stating what it is, how people use it for diabetes, and what the evidence actually shows. The compounds are ordered by how prominently each appears in the research and in real-world use, not ranked as a recommendation of one over another, because the right choice depends entirely on whether someone has Type 1 or Type 2 diabetes, what else they are managing, and what a qualified clinician recommends.

Diabetes 10 min read

dont Spend six hours researching every peptide.

About MyPeptidePal

MyPeptidePal is the world's largest peptide knowledge base and your personal AI peptide expert in one. Trained on every published study and over 10,000 protocols, it gets smarter every day, learning from new research and a community actively running and tracking their own. Build a personalized protocol in 60 seconds, get dosing math you can trust, find vetted suppliers, set auto-pilot reminders, and get straight answers on peptides, health, fitness, and longevity, all in one place. Try for FREE Here, no credit card required.